SSB and peeling skin syndrome: Recent advancements in the understanding of the pathogenesis of pSS have led to the identification of various biomarkers and potential therapeutic targets through molecular genetics and cell biology, including anti-Sjögren’s syndrome-related antigen A (anti-SSA) and anti-Sjögren’s syndrome-related antigen B (anti-SSB) antibodies (13).